Solexa Added To Russell 3000 Index | GenomeWeb
NEW YORK (GenomeWeb News) - Solexa has been added to the Russell 3000 Index, which measures the performance of the 3,000 largest US companies based on total market capitalization, the company said today.
 
Inclusion in the index "should increase Solexa's visibility with institutions that rely on it as part of their investment strategy," said John West, Solexa CEO, in a statement.
 
Solexa's market cap is currently $324 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.